helpfulRider22963

SPRO Final 3rd Testing Successful

Long
NASDAQ:SPRO   Spero Therapeutics, Inc.
I bought this stock too early and watch it get clobbered. Then they announced their drug final 3rd stage testing was successful. This company is a $30 stock but they still have to raise money and go to market. BUT this guarantees they will be successful.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.